Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (172)

Clear all filters
Clear all filters

Bortezomib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

Proteasome Inhibitor

Bosutinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Leukemia)

Drug Class / Mechanism

BCR-ABL Tyrosine Kinase Inhibitor

Carfilzomib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

Proteasome Inhibitor

CC-90009 (Cereblon E3 Ligase Modulator)

Immunomodulatory Agent

Therapeutic Category

Immunomodulatory Agent

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

IMiD (Cereblon Modulator)

Cerdulatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

SYK / Multi-Kinase Inhibitor

Chidamide

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma)

Drug Class / Mechanism

HDAC Inhibitor

CPI-1205 (EZH2 Inhibitor)

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

EZH2 Inhibitor

Crenolanib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (AML)

Drug Class / Mechanism

FLT3 Inhibitor

Daratumumab + Hyaluronidase (SC)

Immunotherapy (Monoclonal Antibody)

Therapeutic Category

Immunotherapy (Monoclonal Antibody)

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

Anti-CD38 / SLAMF7 mAb

Delanzomib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

Proteasome Inhibitor

Denileukin Diftitox

Immunotherapy (Cytokine)

Therapeutic Category

Immunotherapy (Cytokine)

Oncology Type

Hematologic (Lymphoma)

Drug Class / Mechanism

IL-2 / Diphtheria Toxin Fusion Protein, anti-CD25

Elotuzumab

Immunotherapy (Monoclonal Antibody)

Therapeutic Category

Immunotherapy (Monoclonal Antibody)

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

Anti-CD38 / SLAMF7 mAb